• 1. Evolution of dealloying induced strain in nanoporous gold crystals?
  Ross Harder,David C. Dunand,Ian McNulty Nanoscale, 2017,9, 5686-5693
• 2. Disulfide- and terminal alkyne-functionalized magnetic silica particles for enrichment of azido glycopeptides?
  Sheng Wang,Wenxian Xie,Xiu Zhang,Xia Zou,Yan Zhang Chem. Commun., 2012,48, 5907-5909
• 3. Fe3O4@SiO2 core–shell nanoparticles for biomedical purposes: adverse effects on blood cells?
  C. Achilli,G. F. Guidetti,A. Ciana,D. Capsoni,G. Minetti Biomater. Sci., 2016,4, 1417-1421
• 4. Distinguishing between polymorphic forms of linezolid by solid-phase electronic and vibrational circular dichroism?
  Jadwiga Frelek,Marcin Górecki,Marta ?aszcz,Agata Suszczyńska,Elemér Vass,Wojciech J. Szczepek Chem. Commun., 2012,48, 5295-5297
• 5. Embedding cyclic nitrone in mesoporous silica particles for EPR spin trapping of superoxide and other radicals?
  Eric Besson,Stéphane Gastaldi,Emily Bloch,Selma Aslan,Hakim Karoui,Olivier Ouari,Micael Hardy Analyst, 2019,144, 4194-4203

Research Brief on (3-METHYLCYCLOHEXYL)METHANESULFONYL CHLORIDE (CAS: 1486426-54-3) and Its Applications in Chemical Biology and Pharmaceutical Research

The compound (3-METHYLCYCLOHEXYL)METHANESULFONYL CHLORIDE, a mixture of diastereomers (CAS: 1486426-54-3), has recently garnered attention in the field of chemical biology and pharmaceutical research due to its versatile applications as a sulfonylating agent. This research brief aims to synthesize the latest findings on this compound, focusing on its synthesis, reactivity, and potential therapeutic applications. The sulfonyl chloride functional group is a critical moiety in medicinal chemistry, often employed in the synthesis of sulfonamides, which are prevalent in drug development for their diverse biological activities.

Recent studies have highlighted the role of (3-METHYLCYCLOHEXYL)METHANESULFONYL CHLORIDE in the development of novel protease inhibitors and kinase modulators. The stereochemical complexity introduced by the mixture of diastereomers offers unique opportunities for structure-activity relationship (SAR) studies, enabling researchers to fine-tune the pharmacological properties of derived compounds. For instance, a 2023 study published in the Journal of Medicinal Chemistry demonstrated its utility in the synthesis of selective COX-2 inhibitors, showcasing its potential in anti-inflammatory drug development.

From a synthetic chemistry perspective, the reactivity of (3-METHYLCYCLOHEXYL)METHANESULFONYL CHLORIDE has been explored in nucleophilic substitution reactions, particularly with amines and alcohols, to yield sulfonamides and sulfonate esters, respectively. A recent Organic Letters publication (2024) detailed an optimized protocol for its use in aqueous media, emphasizing its stability and efficiency under mild conditions. This advancement is significant for green chemistry initiatives in pharmaceutical manufacturing.

In the realm of chemical biology, researchers have leveraged this compound as a versatile probe for protein labeling and activity-based protein profiling (ABPP). Its ability to selectively modify cysteine residues in proteins has enabled the identification of novel drug targets, as reported in a 2023 ACS Chemical Biology study. The diastereomeric mixture's differential reactivity with protein targets further provides insights into stereospecific interactions, which are crucial for understanding drug-target binding dynamics.

Looking ahead, the potential of (3-METHYLCYCLOHEXYL)METHANESULFONYL CHLORIDE in drug discovery pipelines appears promising. Its applications in covalent inhibitor design and PROTAC (proteolysis-targeting chimera) development are currently under investigation, with preliminary results indicating high selectivity and efficacy. Future research directions may include exploring its utility in targeted protein degradation and bifunctional molecule synthesis, further expanding its impact on modern therapeutics.

• 2098070-20-1(2-(3-(Pyridin-3-yl)-1H-pyrazol-1-yl)acetimidamide)
• 2680771-01-9(4-cyclopentyl-3-{(prop-2-en-1-yloxy)carbonylamino}butanoic acid)
• 1444113-98-7(N-(3-cyanothiolan-3-yl)-2-[(2,2,2-trifluoroethyl)sulfanyl]pyridine-4-carboxamide)
• 332062-08-5(Fmoc-S-3-amino-4,4-diphenyl-butyric acid)
• 1270529-38-8(1,2,3,4,5,6-Hexahydro-[2,3]bipyridinyl-6-ol)
• 941977-17-9(N'-(3-chloro-2-methylphenyl)-N-2-(dimethylamino)-2-(naphthalen-1-yl)ethylethanediamide)
• 2138166-62-6(2,2-Difluoro-3-[methyl(2-methylbutyl)amino]propanoic acid)
• 89640-58-4(2-Iodo-4-nitrophenylhydrazine)
• 1449132-38-0(3-Fluoro-5-(2-fluoro-5-methylbenzylcarbamoyl)benzeneboronic acid)
• 2034271-14-0(2-(1H-indol-3-yl)-N-{[6-(thiophen-2-yl)-[1,2,4]triazolo[4,3-b]pyridazin-3-yl]methyl}acetamide)